penicillin antibiotics Flashcards
5 questions in empiric coverage
What is the patient at risk for?
gram +
Gram-_
anaerobe
atypical
MDRO
bacterial resistance
action of antimicrobial agents
range of targets within bacterial cell
inhibition of bacterial growth or killing the bacterical cell
resistance
reduction oin or loss of the antibacterial effect
resistance mechanisms:
properties or alteration in the bacterium
result in reduced antimicrobial activity
bacteria can be resistant to single or multiple antimicrobials
bacteria mechanisms of resistance
alteration or bypassing of drug target
- altered access to drugs target
modifications of drug activity - resistant bacteria have a combination of mechanisms
- mutations in bacterial chromosomal genes
acquisition of new genes by DNA transfer
acquired oneself replicating plasmids
minimum inhibitory concentration (MIC)
assessing the occurrence and magnitude of resistance
bacterial resistance
transformation
upptake of fragments of enviromental DNA from related bacterial species
Beta-lactates :
antibiotic Degradation
Breakdown of the core of beta-lactam ring
destroys drug activity
beta lactamase inhibitor sublactam or tazobactam little to no antibacterial activity inhibits plasmid medicated beta lactamases
extended spectrum beta lactamase ( ESBL)
ability to inactivate all pencillin’
early generation cephalosproins
Mimimun Inhibitroy concentration (MIC)
incubated organisms given with increasing concentrations
the lowest concentration of antibiotic with no visible growth
MIC or breakpoint
organisms
site of infection
FDA regulation
antibiotics managemetn
based on lowest MIC value
penicillin allergy (beta-lactam )
10% report allergy
90% may be tolerate
cross-reactivity with cephalosporins
2% (newest data)
,1% cross-reactivity with carbapenems
Cephalsoproin allergy
37% in class cross reactivity
true allergy does not correlate to PCN allergy
Penicillinase resistant penicillin ( nafcillin )
Mechanism of action:
inhibits cell wall mucopeptide
bactericidal
clinical application
gram-positive
MSSA
CoNS
CoPS
avoid use
enterococci or MRSA
side effect /adv reaction
acute interstitial nephritis , pheblitis , bone marow suppression
aminopenicillin ( ampicillin)
mechanism of action:
bacteriacydial
inhibits cell wall mucopeptide synthesis
clinical application
some gram-coverage
streptococcus and enterococcus faeclis
CNS coverage
achromyces spp
Borelliea bugdefri
Clostridia
listeria monocyte-genes
Neisseria meningitis
pustruella mulcudia
peptiomplus
avoid use
staphlyococcus
side effect adverse reaction:
rash (65-100% ) with acute mononeucliosis
not a true allergy
aminopenicillin ( ampicillin/sulbactam)
unasyn
mechanism of action:
bactericidal
inhibits cell wall mucopeptide synthesis
inhibits beta lactamases
clinical application
gram + gram - & anerobes
increasing resistance among arobic gram-rods
Haemophilus influenzae or pasturella multicada
common usage
avoid use
streptococcus
side effects/adverse reactions
eosinophelia , phlebitis , fever , rash
antipseudomonal penicilllin
(piperacillin/tazobactam) zosyn
mechanism of action
bacterialcidal
pripecillin inhibits cell wall mucopeptide syntheis
tazabactam inhibitsbeta-lactmaces
clinical application:
gram + MSSA streptococcus
gram - GNR
anaerobes
MDRO ( pseudomonas)
avoid use
ESBL
side effects adverse reaction
aki with vancomycin
impaired platelet aggeration
bone marrow suppression